a genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis

Medication for reducing signs and symptoms and delaying structural damage in patients with moderately to severely active rheumatoid arthritis. Some patients treated with Enbrel® are reported to have developed serious infections.